Author:
Chong Li,Ma Guoyi,Bartier Wendy A.,Tattersall Martin H. N.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference35 articles.
1. Borsa J, Whitmore GF (1969) Cell killing studies on the mode of action methotrexate on L-cells in vitro. Cancer Res 29:737–744
2. Taylor IW, Slowiaczek P, Francis PR, Tattersall MHN (1982) Purine modulation of methotrexate cytotoxicity in mammalian cell lines. Cancer Res 45:5159–5164
3. Piper AA, Nott SE, MacKinnon WB, Tattersall MHN (1983) Critial modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells. Cancer Res 43:5101–5105
4. Sobrero AF, Bertino JR (1986) Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assay using undialysed fetal bovine serum. Int J Cell Cloning 4:51–62
5. Hughes JM, deFazio A, Tattersall MHN (1988) Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay. Brit J Cancer 57:459–463